NL-OMON47795已完成不适用
Q-VaxCelerate: Development of a T Cell-Based Vaccine for Q Fever - Q-VaxCelerate
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 173
研究概览
简要总结
Trial is onging in other countries
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Participants in this study have been exposed to Coxiella burnetii resulting in
- •chronic Q fever, resolved acute Q fever, or have a strong T cell mediated
- •immune response to Coxiella without having any clinical symptoms. A control
- •group consisting of people without a Cb immune response will be recruited. In
- •addition, a group that was vaccinated with Q-VAX in 2011 in the RIVM/GGD
- •campaign for people with an increased risk of chronic Q fever will be included.
排除标准
- •blood-transmissable infectious disease
- •known immune disease
- •use of immune suppressives
研究者
相似试验
已完成
不适用
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV2 immunoglobulinesNL-OMON51004Erasmus MC, Universitair Medisch Centrum Rotterdam44
已完成
不适用
T-cell mediated immunity against Aspergillus fumigatusAspergillosisfungal infection1000170810017528NL-OMON35724eids Universitair Medisch Centrum9
已完成
不适用
Investigating the immune response to COVID-19 Vaccination in Lung Transplantation patients (COVALENT study)lung transplantation100276651004743810024970NL-OMON52266niversitair Medisch Centrum Groningen180
已完成
不适用
Immune responses Induced by Vaccination Against COVID-19 in Dutch healthy subjectsimmuunsysteemcoronaprevention10047438NL-OMON51214Ministerie van Volksgezondheid, Welzijn en Sport (VWS)1,459
已完成
不适用
An open-label, adaptive multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of RO7234292 in csf and plasma, and safety and tolerability following intrathecal administration in patients with Huntington's disease.Chronic Progressive Choreadegenerative chorea1002929910029317NL-OMON49037Hoffmann-La Roche4